City

Shanghai (1)

Condition

Acute T Cell Leukemia (2)

Anaplastic Lymphoma (1)

Angioimmunoblastic T-cell Lymphoma (1)

Peripheral T Cell Lymphoma (1)

T-lymphoblastic Lymphoma (1)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)

Sichuan University (1)

Collaborator

Intervention

anti-trbc1 car-t cell therapy (1)

prednisone (1)

ruxolitinib (1)

vincristine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

acute t cell leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Peripheral T Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Anaplastic Lymphoma Trial in Shanghai (anti-TRBC1 CAR-T cell

Recruiting

Peripheral T Cell Lymphoma
+4 more

anti-TRBC1 CAR-T cell therapy

Shanghai, Shanghai, China

Xianmin Song

Mar 31, 2021

Acute T Cell Leukemia Trial (Ruxolitinib, Vincristine, Prednisone)

Unknown status

Acute T Cell Leukemia

Ruxolitinib
+2 more

(no location specified)

Aug 1, 2018